In vivo device with balloon stabilizer and valve

• US 20070249900A1
• Filed: 01/19/2007
• Published: 10/25/2007
• Est. Priority Date: 01/19/2006
• Status: Abandoned Application

• Current Assignee: CapsoVision, Inc.
• Original Assignee: CapsoVision, Inc.
• Inventors: Wilson, Gordon, Wang, Kang-Huai
• Application Number:
  US11/655,639
• Publication Number:
  US 20070249900A1
• Time in Patent Office: Days
• US Class Current: 600/116
• CPC Class Codes: A61B 1/00036 Means for power saving, e.g. sleeping mode
• CPC Class Codes: A61B 1/00082 Balloons
• CPC Class Codes: A61B 1/00148 using anchoring means
• CPC Class Codes: A61B 1/041 Capsule endoscopes for imaging
• CPC Class Codes: A61B 5/073 Intestinal transmitters

Abstract

An in vivo imaging system is provided with a capsule having at least one balloon configured to orient the capsule in a consistent orientation relative to an internal organ; at least one valve configured to control the quantity of gas within the at least one balloon; and an imager encased within the capsule.

Claims

1. An in vivo imaging system comprising:

a capsule having at least one balloon configured to orient the capsule in a consistent orientation relative to an internal organ;

at least one valve configured to control the quantity of gas within the at least one balloon; and

an imager encased within the capsule.

2. An in vivo system according to 1, further comprising a deflation valve configured to deflate the at least one balloon upon a predetermined event.

3. An in vivo system according to claim 2, wherein the event is a change in pressure.

4. An in vivo system according to claim 2, further comprising a pressure detector, wherein the at least one deflation valve is configured to deflate the balloons upon the detection of a change in pressure.

5. An in vivo system according to claim 3, further comprising a pressure detector, wherein the at least one deflation valve configured to deflate the balloons upon a change in pressure by puncturing a membrane of the valve.

6. An in vivo imaging system according to claim 2, wherein the deflation valve is a normally opened valve, such that the valve is held closed when power is applied to the valve, wherein the at least one balloon is configured to deflate when power is removed and the valve is opened.

7. An in vivo imaging system according to claim 2, wherein the deflation valve is a normally opened valve, such that the valve is held closed by a mechanism applied to the valve, wherein the at least one balloon is configured to deflate when the mechanism is removed and the valve is opened.

8. An in vivo imaging system according to claim 2, wherein the deflation valve is a normally opened valve, such that the valve is held closed by a mechanism when power is applied to the valve, wherein the at least one balloon is configured to deflate when power is removed and the valve is opened.

9. An in vivo imaging system according to claim 2, wherein the deflation valve includes a membrane, such that the membrane seals the at least one balloon closed, wherein the at least one balloon is configured to deflate when the membrane is ruptured.

10. An in vivo imaging system according to claim 2, further comprising a pair of balloons located at opposite ends of the capsule, and at least one release valve configured to actuate when a predetermined balloon pressure is detected to deflate the balloons upon the occurrence of the predetermined pressure.

11. An in vivo imaging system according to claim 10, further comprising a release valve configured to puncture a barrier when a predetermined balloon pressure is detected to deflate the balloons upon the occurrence of the predetermined pressure while traveling through an organ.

12. An in vivo imaging system according to claim 10, further comprising a release valve configured to automatically puncture a barrier [membrane of FIG. 3] to deflate the balloons upon the occurrence of the predetermined pressure while traveling through an organ.

13. An in vivo imaging system according to claim 2, further comprising balloons located at opposite ends of the capsule, a motion detector, and a release valve configured to deflate the balloons when the motion detector determines that the capsule has not progressed significantly for a predetermined period of time.

14. An in vivo imaging system according to claim 2, further comprising a motion detector and a release valve configured to deflate the at least one balloon when the motion detector determines that the capsule has not progressed significantly over the course of some number of sequential image captures.

15. An in vivo imaging system according to claim 2, further comprising a release valve configured to deflate the at least one balloon when the motion detector determines that the capsule has not progressed over the course of a predetermined number of sequential image captures.

16. An in vivo imaging system according to claim 1, further comprising an inflation valve, wherein the at least one balloon is configured to expand when the inflation valve is actuated to stabilize the orientation of the capsule while traveling through the internal organ.

17. An in vivo system according to claim 16, wherein the inflation valve is a mechanism configure to release an expansive substance to inflate the at least one balloon when the mechanism is actuated.

18. An in vivo system according to claim 17, wherein the expansive substance is a liquid.

19. An in vivo system according to claim 17, wherein the expansive substance is a gas.

20. An in vivo system according to claim 17, wherein the expansive substance is a combination of liquid and gas.

21. An in vivo system according to claim 17, wherein the mechanism is a membrane.

22. An in vivo system according to claim 21, further comprising an electrical element configured to remove the membrane to release a substance to inflate the at least one balloon.

23. An in vivo imaging system according to claim 16, wherein the capsule is configured to capture images while traveling through a gastrointestinal track, where the in vivo camera system operates in a first confined mode while traveling through the small intestine and in a second expanded mode while subsequently traveling through the colon, wherein the at least one balloon is configured to expand when the deflation valve is activated by the occurrence of an event at two ends of the capsule to stabilize the orientation of the capsule while in the large intestine.

24. An in vivo imaging system according to claim 1, further comprising two balloons located at opposite ends of the capsule and configured to inflate at opposite ends of the capsule using a phase transition that is activated upon the occurrence of an event, where the valve is configured to initiate the phase transition and to inflate the balloons to stabilize the orientation of the capsule.

25. An in vivo imaging system according to claim 24, wherein prior to inflation the system includes a vial containing a solution such that the total vapor pressure of the solution is substantially equal to a predetermined value, such that the balloon pressure upon inflation with vapor will not exceed this predetermined value.

26. An in vivo imaging system according to claim 24, wherein the system further includes a vial containing a substance that, when released by the valve upon an event, causes the balloon to expand to a predetermined pressure according to the substance characteristics and the balloon architecture.

27. An in vivo imaging system according to claim 26, wherein the event is the expiration of a predetermined amount of time.

28. An in vivo imaging system according to claim 26, wherein the event is the reception of a remote actuation signal.

29. An in vivo imaging system according to claim 24, further comprising at least one reserve configured to store an expandable gas and an electronic balloon actuator configured to cause the valve to release the expandable gas from the reserve to inflate the balloons located at opposite ends of the capsule.

30. An in vivo imaging system according to claim 24, further comprising at least one reserve configured to store a mixture of substances that is at least partially in the liquid state, wherein the balloon actuator is configured to cause the valve to release at least one substance from the reserve to inflate the balloons located at opposite ends of the capsule, wherein at least a portion of the substance released vaporizes.

31. An in vivo imaging system according to claim 24, wherein the balloons are configured to inflate at opposite ends of the capsule using a chemical reaction that is activated upon the occurrence of an event to open one or more valves to mix the chemicals in the balloon and initiate the chemical reaction that generates a gas to expand the balloons and to stabilize the capsule.